RayBiotech specializes in advanced protein analysis technologies, offering a wide range of products and services designed to facilitate research in proteomics. Their portfolio includes various types of arrays, such as antibody arrays, cytokine arrays, and high-density arrays, which allow for the simultaneous detection and quantification of multiple proteins. These arrays are particularly useful for profiling post-translational modifications (PTMs) and biomarkers across a diverse range of species, including humans, mice, and rats. RayBiotech's proprietary TruExp™ mammalian cell expression system is notable for producing recombinant proteins with native conformations and complex PTMs, ensuring high-quality outputs for research applications.

In addition to their array technologies, RayBiotech provides comprehensive protein expression and purification services, which encompass the entire workflow from gene synthesis to protein purification. Their services are designed to be fast, scalable, and high-quality, achieving over 95% purity in many cases. The company also offers custom solutions, including the development of custom arrays and antibodies tailored to specific research needs. With a focus on innovation and quality, RayBiotech has established itself as a leader in the field of protein analysis, supporting a wide array of research areas, including cancer, infectious diseases, and autoimmune disorders.

United States

RayBiotech is a leading life sciences company providing proteomic discovery tools to scientists in 85 countries worldwide. RayBiotech is committed to accelerating research through innovation, leadership, and excellent products and service.

RayBiotech

Company Details